Sastasundar Ventures Limited (NSE:SASTASUNDR)
265.30
-4.60 (-1.70%)
May 22, 2025, 3:29 PM IST
Sastasundar Ventures Revenue
Sastasundar Ventures had revenue of 2.69B INR in the quarter ending December 31, 2024, a decrease of -31.72%. This brings the company's revenue in the last twelve months to 11.84B, down -17.23% year-over-year. In the fiscal year ending March 31, 2024, Sastasundar Ventures had annual revenue of 14.31B with 34.95% growth.
Revenue (ttm)
11.84B
Revenue Growth
-17.23%
P/S Ratio
0.73
Revenue / Employee
12.58M
Employees
941
Market Cap
8.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 14.31B | 3.71B | 34.95% |
Mar 31, 2023 | 10.61B | 4.22B | 66.06% |
Mar 31, 2022 | 6.39B | 879.80M | 15.98% |
Mar 31, 2021 | 5.51B | 1.64B | 42.39% |
Mar 31, 2020 | 3.87B | 1.67B | 75.72% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 271.45B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |